packageAsciminib

asciminib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Asciminib is a BCR-ABL tyrosine kinase inhibitor used to treat chronic myeloid leukemia. It is authorised in the European Union for BCR-ABL positive chronic myelogenous leukemia.

Summary written by glm-5.3-flash from Wikidata Q27074535 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:asciminib
ATC codes:L01EA06
DrugBank:DB12597
PubChem CID:72165228
Wikidata:Q27074535
formula:C20H18ClF2N5O3
molar mass:449.842 g/mol (PubChem CID 72165228)
logP:3 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown